Valion Bio, Inc.
VBIO· Nasdaq
VBIOValion Bio, Inc.
Who holds Valion Bio, Inc., from the managers’ Form 13F reports for the quarter ended Jun 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Murchinson Ltd. | 115K | New | $59.8K | 0.1% | Aug 14, 2026 |
| Citadel Advisors LLC | 74.1K | New | $38.5K | 0% | Sep 2, 2026 |
| Sanctuary Advisors, LLC | 61.2K | ±0% | $31.8K | 0.1% | Aug 13, 2026 |
| Marex Group plc | 54.3K | −8.4% | $28.2K | 0.1% | Aug 14, 2026 |
| Geode Capital Management, LLC | 19.4K | −77.9% | $10.1K | 0% | Aug 12, 2026 |
| UBS Group AG | 11.1K | +368.9% | $5.8K | 0% | Aug 13, 2026 |
| Two Sigma Securities, LLC | 10.2K | New | $5.3K | 0.1% | Aug 14, 2026 |
| Tower Research Capital LLC (TRC) | 2.1K | +258.7% | $1.1K | 0% | Aug 11, 2026 |
| Virtu Financial LLC | 39.2K | New | $20 | 0.1% | Aug 13, 2026 |
| SBI Securities Co., Ltd. | 16 | ±0% | $8 | 0% | Jul 23, 2026 |
| HRT Financial LP | 11.5K | −73.0% | $5 | 0% | Aug 14, 2026 |
| TD Waterhouse Canada Inc. | 5 | New | $2 | 0% | Jul 27, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | ±0% | $1 | 0% | Aug 5, 2026 |
